These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unit. Schultz MJ; Baas MC; van der Sluijs HP; Stamkot GA; Smit W Curr Med Chem; 2006; 13(21):2565-70. PubMed ID: 17017911 [TBL] [Abstract][Full Text] [Related]
5. Prevention of contrast-induced nephropathy in vascular surgery patients. Lawlor DK; Moist L; DeRose G; Harris KA; Lovell MB; Kribs SW; Elliot J; Forbes TL Ann Vasc Surg; 2007 Sep; 21(5):593-7. PubMed ID: 17823041 [TBL] [Abstract][Full Text] [Related]
6. Prevention of iodinated contrast-induced nephropathy. Li JH; He NS Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345 [TBL] [Abstract][Full Text] [Related]
7. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions. Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445 [TBL] [Abstract][Full Text] [Related]
9. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials. Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735 [TBL] [Abstract][Full Text] [Related]
10. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures. El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601 [TBL] [Abstract][Full Text] [Related]
11. Pravastatin versus simvastatin for prevention of contrast-induced nephropathy. Muñoz MA; Maxwell PR; Green K; Hughes DW; Talbert RL J Cardiovasc Pharmacol Ther; 2011; 16(3-4):376-9. PubMed ID: 21386035 [TBL] [Abstract][Full Text] [Related]
12. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography. Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594 [TBL] [Abstract][Full Text] [Related]
13. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography. Fishman EK; Reddan D Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820 [TBL] [Abstract][Full Text] [Related]
14. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial. Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489 [TBL] [Abstract][Full Text] [Related]
15. Prevention of contrast-induced nephropathy: an overview. Ellis JH; Cohan RH Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595 [TBL] [Abstract][Full Text] [Related]
16. Contrast medium-induced nephropathy: strategies for prevention. Massicotte A Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385 [TBL] [Abstract][Full Text] [Related]